Peroxisome Proliferator-Activated Receptor (PPARγ) Plays a Protective Role in Cigarette Smoking-Induced Inflammation via AMP-Activated Protein Kinase (AMPK) Signaling

Abstract

BackgroundCigarette smoking is a well-known risk factor in multiple chronic pulmonary diseases. This study aims to investigate the role of peroxisome proliferator-activated receptor (PPAR) γ in cigarette smoking-induced inflammation.Material/MethodsCigarette smoking extract (CSE) was employed to induce inflammation in bronchial epithelial cells (BECs). After CSE administration, several autophagy-related proteins (Beclin1, autophagy-related gene (ATG)5, ATG7, p62, and LC3) and PPARγ levels were examined by western blot. Subsequently, PPARγ agonists and antagonist were used to treat CSE-induced BECs, several inflammatory factors (interleukin (IL)-6, IL-8, inducible nitric oxide synthase (iNOS), and cyclooxygenase (COX)-2) and autophagy-related proteins were detected to measure the inflammatory and autophagy levels. Then LC3 knockdown was performed to verify the role of autophagy in CSE-induced inflammation. Finally, the AMP-activated protein kinase (AMPK) and its downstream S6 kinase (S6K) were detected in CSE-stimulated BECs.ResultsCSE administration caused insufficient autophagy and the decrease of PPARγ in BECs. The PPARγ agonists ameliorate the CSE-induced inflammation and promote the autophagy development, evidenced by the changes of inflammatory factors and autophagy-related proteins. Loss-of-function experiments demonstrated that the PPARg played an anti-inflammatory role in an autophagy-dependent manner. In addition, CSE administration inactivated the AMPK signaling, which was restored by PPARγ agonists. The effects of PPARγ agonists on inflammation and autophagy could be abolished by AMPK inhibitor.ConclusionsWe demonstrated that PPARγ played a protective role in CSE-induced inflammation and autophagy by activating AMPK signaling in BECs, which may provide investigation basis for clinical therapy of chronic pulmonary diseases.

AMPK: a balancer of the renin–angiotensin system

“…Current research shows PPARs and AMPK are also closely related. PPARs may activate AMPK [178][179][180]. One study claims that PPARγ agonists enhanced AMPK phosphorylation [179].…”

“…PPARs may activate AMPK [178][179][180]. One study claims that PPARγ agonists enhanced AMPK phosphorylation [179]. The other finding suggests that micheliolide ameliorates liver steatosis by upregulating PPAR-γ expression, thereby inhibiting NF-κB-mediated inflammation and activating AMPK/mTOR-dependent autophagy [180].…”

Curcumin nanomicelle versus curcumin improves lipid profile, stress oxidative factors and inflammatory markers in patients undergoing coronary elective angioplasty; A Randomized Clinical Trial

“…Enhancing of the expression of hepatic CYP7A1 gene by curcumin consumption, resulted in reducing the blood cholesterol levels and approved the hypocholesterolemic properties of curcumin [30]. Expression of AMP-activated protein kinase and peroxisome proliferator-activated receptor boosted by curcumin that affected energy metabolism of subcutaneous adipocyte tissue in mice that treated with curcumin-supplemented high fat diet [31].…”

Peroxisome Proliferator-Activated Receptors and Caloric Restriction—Common Pathways Affecting Metabolism, Health, and Longevity

“…In a model of cigarette smoking extract (CSE)-induced inflammation in a human bronchial epithelial cell line (16HBE), PPARγ plays an anti-inflammatory role in an autophagy-dependent manner. In this model, PPARγ activation promotes autophagy by phosphorylating and activating AMPK (see the AMPK and PPARγ section) [ 261 ]. Accordingly, the PPARγ agonists TZDs inhibit IGF-1-induced p70S6K phosphorylation at sites specifically phosphorylated by mTOR as well as dephosphorylating a downstream factor, S6K, through AMPK activation [ 262 ].…”